Stemming the Hype: What can we learn from iPSC models of parkinson's disease and how can we learn it?

Journal of Parkinson's Disease

Volumn 4, Issue 1, 2014, Pages 15-27

  Jacobs, Benjamin Meir ^a  

^a MAGDALEN COLLEGE   (United Kingdom)

Author keywords

Disease model; in vitro; induced pluripotent stem cells; neurodegeneration; Parkinson's disease; stem cell

Indexed keywords

ALPHA SYNUCLEIN; LEUCINE RICH REPEAT KINASE 2;

BIOLOGICAL MODEL; CLINICAL EVALUATION; CLINICAL RESEARCH; DOPAMINERGIC NERVE CELL; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; LRRK2 GENE; MUTATOR GENE; NEURAL STEM CELL; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PARK2 GENE; PARKINSON DISEASE; PHENOTYPE; PINK1 GENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SNCA GENE; SOMATIC CELL;

DISEASE MODEL; IN VITRO; INDUCED PLURIPOTENT STEM CELLS; NEURODEGENERATION; PARKINSON'S DISEASE; STEM CELL;

HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; PARKINSON DISEASE;

EID: 84898991584     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-130268     Document Type: Review

References (60)

1. de Lau LM, & Breteler MM (2006) Epidemiology of Parkinson's disease. Lancet Neurol, 5, 525-535 (Pubitemid 44262284)
2. Shulman JM, De Jager PL, & Feany MB (2011) Parkinson's disease: Genetics and pathogenesis. Annu Rev Pathol, 6, 193-222
3. Takahashi K, & Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676 (Pubitemid 44233629)
4. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, & Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872 (Pubitemid 350138099)
5. Alberio T, Lopiano L, & Fasano M (2012) Cellular models to investigate biochemical pathways in Parkinson's disease. FEBS J, 279, 1146-1155
6. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, & Daley GQ (2008) Disease-specific induced pluripotent stem cells. Cell, 134, 877-886
7. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, & Eggan K (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218-1221
8. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, & Jaenisch R (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136, 964-977
9. Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P,KeeK, Schule B, Dolmetsch RE, LangstonW, Palmer TD,&Pera RR (2011) LRRK2 mutant iPSC-derivedDAneurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell, 8, 267-280
10. Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, Jimenez-Delgado S, Caig C, Mora S, Di Guglielmo C, Ezquerra M, Patel B, Giralt A, Canals JM,Memo M, Alberch J, Lopez-Barneo J, Vila M, Cuervo AM, Tolosa E, Consiglio A, & Raya A (2012) Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med, 4, 380-395
11. Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, SundbergM,McLean JR, Carrillo-Reid L, Xie Z, Osborn T, Hargus G, Deleidi M, Lawson T, Bogetofte H, Perez-Torres E, Clark L, Moskowitz C, Mazzulli J, Chen L, Volpicelli- Daley L, Romero N, Jiang H, Uitti RJ, Huang Z, Opala G, Scarffe LA, Dawson VL, Klein C, Feng J, Ross OA, Trojanowski JQ, Lee VM,Marder K, Surmeier DJ, Wszolek ZK, Przedborski S, Krainc D, Dawson TM, & Isacson O (2012) Pharmacological rescue of mitochondrial deficits in iPSCderived neural cells from patients with familial Parkinson's disease. Sci Transl Med, 4, 141ra190
12. Liu GH, Qu J, Suzuki K, Nivet E, Li M, Montserrat N, Yi F, Xu X, Ruiz S, Zhang W, Wagner U, Kim A, Ren B, Li Y, Goebl A, Kim J, Soligalla RD, Dubova I, Thompson J,Yates J, 3rd, Esteban CR, Sancho-Martinez I, & Izpisua Belmonte JC (2012) Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature, 491, 603-607
13. Orenstein SJ, Kuo SH, Tasset I, Arias E, Koga H, Fernandez- Carasa I, Cortes E, Honig LS, Dauer W, Consiglio A, Raya A, Sulzer D, & Cuervo AM (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci, 16, 394-406
14. Devine MJ, Ryten M, Vodicka P, Thomson AJ, Burdon T, Houlden H, Cavaleri F, Nagano M, Drummond NJ, Taanman JW, Schapira AH, Gwinn K, Hardy J, Lewis PA, & Kunath T (2011) Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun, 2, 440
15. Byers B, Cord B, Nguyen HN, Schule B, Fenno L, Lee PC, Deisseroth K, Langston JW, Pera RR, & Palmer TD (2011) SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS ONE, 6, e26159
16. Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, Azabdaftari G, Nakaso K, Yan Z, & Feng J (2012) Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun, 3, 668
17. Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, Hayakawa H, Nihira T, Kobayashi T, Ohyama M, Sato S, Takanashi M, Funayama M, Hirayama A, Soga T, Hishiki T, Suematsu M, Yagi T, Ito D, Kosakai A, Hayashi K, Shouji M, Nakanishi A, Suzuki N, Mizuno Y, Mizushima N, Amagai M, Uchiyama Y, Mochizuki H, Hattori N, & Okano H (2012) Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2iPSC-derived neurons and postmortem brain tissue. Mol Brain, 5, 35
18. Aboud AA, Tidball AM, Kumar KK, Neely MD, Ess KC, Erikson KM, & Bowman AB (2012) Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects. Neurotoxicology, 33, 1443-1449
19. Seibler P, Graziotto J, Jeong H, Simunovic F, Klein C, & Krainc D (2011) Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci, 31, 5970-5976
20. Rakovic A, Shurkewitsch K, Seibler P, Grunewald A, Zanon A, Hagenah J, Krainc D, & Klein C (2013) Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)- dependent ubiquitination of endogenous Parkin attenuates mitophagy: Study in human primary fibroblasts and induced pluripotent stem cell-derived neurons. J Biol Chem, 288, 2223-2237
21. Mazzulli JR, Xu YH, SunY, Knight AL, McLean PJ, Caldwell GA, SidranskyE, Grabowski GA,&KraincD(2011) Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell, 146, 37-52
22. Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H,&Suzuki N (2011) Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet, 20, 4530-4539
23. Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, Carson CT, Laurent LC, Marsala M, Gage FH, Remes AM, Koo EH, & Goldstein LS (2012) Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature, 482, 216-220
24. ShiY, Kirwan P, Smith J, MacLean G, Orkin SH,&Livesey FJ (2012) A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci Transl Med, 4, 124ra129
25. An MC, Zhang N, Scott G, Montoro D,Wittkop T, Mooney S, Melov S, & Ellerby LM (2012) Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. Cell Stem Cell, 11, 253-263
26. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes (2012). Cell Stem Cell 11, 264-278
27. Zhang N, An MC, Montoro D, & Ellerby LM (2010) Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells. PLoS Curr, 2, RRN1193
28. Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J, Shim SH, Choi C, Chang DJ, Kwon J, Oh SH, Shin DA, Kim HS, Do JT, Lee DR, Kim M, Kang KS, Daley GQ, Brundin P, & Song J (2012) Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells, 30, 2054-2062
29. Camnasio S, Delli Carri A, Lombardo A, Grad I, Mariotti C, Castucci A, Rozell B, Lo Riso P, Castiglioni V, Zuccato C, Rochon C, Takashima Y, Diaferia G, Biunno I, Gellera C, Jaconi M, Smith A, Hovatta O, Naldini L, Di Donato S, Feki A, & Cattaneo E (2012) The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis, 46, 41-51
30. Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, & Song H (2012) Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Mol Brain, 5, 17
31. Koch P, Breuer P, Peitz M, Jungverdorben J, Kesavan J, Poppe D, Doerr J, Ladewig J, Mertens J, Tuting T, Hoffmann P, Klockgether T, Evert BO, Wullner U, & Brustle O (2011) Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease. Nature, 480, 543-546
32. Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, Wilmut I, Finkbeiner S, Maniatis T, Shaw CE, & Chandran S (2012) Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A, 109, 5803-5808
33. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, & Inoue H (2012) Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med, 4, 145ra104
34. Mitne-Neto M, Machado-Costa M, Marchetto MC, Bengtson MH, Joazeiro CA, Tsuda H, Bellen HJ, Silva HC, Oliveira AS, Lazar M, Muotri AR, & Zatz M (2011) Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet, 20, 3642-3652
35. Almeida S, Zhang Z, Coppola G, MaoW, Futai K, Karydas A, GeschwindMD,TartagliaMC,Gao F, Gianni D, Sena-Esteves M, Geschwind DH, Miller BL, FareseRVJr,&Gao FB (2012) Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Rep, 2, 789-798
36. Reinhardt P, Schmid B, Burbulla LF, Schondorf DC, Wagner L, Glatza M, Hoing S, Hargus G, Heck SA, Dhingra A, Wu G, Muller S, Brockmann K, Kluba T, Maisel M, Kruger R, Berg D, Tsytsyura Y, Thiel CS, Psathaki OE, Klingauf J, Kuhlmann T, Klewin M, Muller H, Gasser T, Scholer HR, & Sterneckert J (2013) Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell, 12, 354-367
37. Cookson MR (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci, 11, 791-797
38. Sanders LH, Laganiere J, Cooper O, Mak SK, Vu BJ, Huang YA, Paschon DE, Vangipuram M, Sundararajan R, Urnov FD, Langston JW, Gregory PD, Zhang HS, Greenamyre JT, Isacson O, & Schule B (2013) LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction. Neurobiol Dis, 62C 381-386
39. Sheng ZH, & Cai Q (2012) Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci, 13, 77-93
40. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, & Gwinn-Hardy K (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 841 (Pubitemid 37339619)
41. Chung CY, Khurana V, Auluck PK, Tardiff DF, Mazzulli JR, Soldner F, Baru V, Lou Y, Freyzon Y, Cho S, Mungenast AE, Muffat J, Mitalipova M, Pluth MD, Jui NT, Schule B, Lippard SJ, Tsai LH, Krainc D, Buchwald SL, Jaenisch R,&Lindquist S (2013) Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science, 342, 983-987
42. Ryan SD, Dolatabadi N, Chan SF, Zhang X, Akhtar MW, Parker J, Soldner F, Sunico CR, Nagar S, Talantova M, Lee B, Lopez K, Nutter A, Shan B, Molokanova E, Zhang Y, Han X, Nakamura T, Masliah E, Yates JR, 3rd, Nakanishi N, Andreyev AY, Okamoto S, Jaenisch R, Ambasudhan R, & Lipton SA (2013) Isogenic Human iPSC Parkinson's Model Shows Nitrosative Stress-Induced Dysfunction in MEF2- PGC1alpha Transcription. Cell, 155, 1351-1364
43. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrane J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, & Przedborski S (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A, 107, 378-383
44. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ, Ku S, Martynova M, Semechkin R, Galat V, Gottesfeld J, Izpisua Belmonte JC, Murry C, Keirstead HS, Park HS, Schmidt U, Laslett AL, Muller FJ, Nievergelt CM, Shamir R, & Loring JF (2011) Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell, 8, 106-118
45. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz- Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS,& Zhang K (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature, 471, 63-67
46. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, & Benvenisty N (2010) Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell, 7, 521-531
47. Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, & Eggan K (2012) Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell, 10, 595-609
48. Polo JM, Liu S, Figueroa ME, KulalertW, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, Natesan S,Wagers AJ, Melnick A, Evans T, & Hochedlinger K (2010) Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol, 28, 848-855
49. Kim K, Doi A,Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, & Daley GQ (2010) Epigenetic memory in induced pluripotent stem cells. Nature, 467, 285-290
50. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Huo H, Loh YH, Aryee MJ, Lensch MW, Li H, Collins JJ, Feinberg AP, & Daley GQ (2011) Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol, 29, 1117-1119
51. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ, Yu J, Hebrok M, Hochedlinger K, Costello JF, Song JS, & Ramalho-Santos M (2011) Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol, 13, 541-549
52. Soldner F, Laganiere J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V, Golbe LI, Myers RH, Lindquist S, Zhang L, Guschin D, Fong LK, Vu BJ, Meng X, Urnov FD, Rebar EJ, Gregory PD, Zhang HS, & Jaenisch R (2011) Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell, 146, 318-331
53. Hockemeyer D,Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC, Zeitler B, Cherone JM,Meng X, Hinkley SJ, Rebar EJ, Gregory PD, Urnov FD,& Jaenisch R (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol, 29, 731-734
54. Sanchez-Danes A, Consiglio A, Richaud Y, Rodriguez-Piza I, Dehay B, Edel M, Bove J, Memo M, Vila M, Raya A, & Izpisua Belmonte JC (2012) Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum Gene Ther, 23, 56-69
55. Pfisterer U, Kirkeby A, Torper O,Wood J, Nelander J, Dufour A, Bjorklund A, Lindvall O, Jakobsson J,&ParmarM(2011) Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A, 108, 10343-10348
56. Caiazzo M, Dell'Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, Sotnikova TD, Menegon A, Roncaglia P, Colciago G, Russo G, Carninci P, Pezzoli G, Gainetdinov RR, Gustincich S, Dityatev A, & Broccoli V (2011) Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature, 476, 224-227
57. Halliday GM, & Stevens CH (2011) Glia: Initiators and progressors of pathology in Parkinson's disease. Mov Disord, 26, 6-17
58. Roybon L, Lamas NJ, Garcia-Diaz A, Yang EJ, Sattler R, Jackson-Lewis V, Kim YA, Kachel CA, Rothstein JD, Przedborski S, Wichterle H, & Henderson CE (2013) Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep, 4, 1035-1048
59. Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, Yow A, Soldner F, Hockemeyer D, Hallett PJ, Osborn T, Jaenisch R, & Isacson O (2010) Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A, 107, 15921-15926
60. Xue Y, Cai X, Wang L, Liao B, Zhang H, Shan Y, Chen Q, Zhou T, Li X, Hou J, Chen S, Luo R, Qin D, Pei D, & Pan G (2013) Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells. PLoS ONE, 8, e70573.